non-enantiomer analysis
非對映異構體分析
identifying non-enantiomers
鑑定非對映異構體
non-enantiomer content
非對映異構體含量
presence of non-enantiomers
非對映異構體的存在
non-enantiomer separation
非對映異構體分離
detecting non-enantiomers
檢測非對映異構體
non-enantiomer impurity
非對映異構體雜質
non-enantiomer ratio
非對映異構體比例
assessing non-enantiomers
評估非對映異構體
non-enantiomer standard
非對映異構體標準
the drug candidate was identified as a non-enantiomer, complicating the synthesis process.
該藥物候選物被鑒定為非對映異構體，使合成過程變得複雜。
our research focused on the separation of a non-enantiomer mixture using chiral chromatography.
我們的研究重點是使用手性色譜法分離非對映異構體混合物。
the non-enantiomer exhibited significantly lower biological activity compared to the desired enantiomer.
與期望的對映異構體相比，非對映異構體表現出顯著較低的生物活性。
we analyzed the product to confirm the absence of a non-enantiomer impurity.
我們分析了產品以確認不存在非對映異構體雜質。
the non-enantiomer's properties were thoroughly investigated for potential applications.
對非對映異構體的特性進行了深入研究，以評估其潛在應用。
the synthesis yielded a racemic mixture containing a non-enantiomer component.
合成產生了一種含有非對映異構體成分的外消旋混合物。
regulatory guidelines require strict control of non-enantiomer levels in pharmaceutical products.
法規指南要求對藥品中的非對映異構體含量進行嚴格控制。
the chiral shift revealed the presence of a non-enantiomer in the sample.
手性位移揭示了樣本中存在非對映異構體。
we developed a new method for selectively removing the non-enantiomer from the reaction mixture.
我們開發了一種新方法，用於選擇性地從反應混合物中去除非對映異構體。
the non-enantiomer's impact on the overall reaction kinetics was carefully assessed.
仔細評估了非對映異構體對整體反應動力學的影響。
the presence of a non-enantiomer can affect the drug's efficacy and safety profile.
非對映異構體的存在可能影響藥物的療效和安全性。
non-enantiomer analysis
非對映異構體分析
identifying non-enantiomers
鑑定非對映異構體
non-enantiomer content
非對映異構體含量
presence of non-enantiomers
非對映異構體的存在
non-enantiomer separation
非對映異構體分離
detecting non-enantiomers
檢測非對映異構體
non-enantiomer impurity
非對映異構體雜質
non-enantiomer ratio
非對映異構體比例
assessing non-enantiomers
評估非對映異構體
non-enantiomer standard
非對映異構體標準
the drug candidate was identified as a non-enantiomer, complicating the synthesis process.
該藥物候選物被鑒定為非對映異構體，使合成過程變得複雜。
our research focused on the separation of a non-enantiomer mixture using chiral chromatography.
我們的研究重點是使用手性色譜法分離非對映異構體混合物。
the non-enantiomer exhibited significantly lower biological activity compared to the desired enantiomer.
與期望的對映異構體相比，非對映異構體表現出顯著較低的生物活性。
we analyzed the product to confirm the absence of a non-enantiomer impurity.
我們分析了產品以確認不存在非對映異構體雜質。
the non-enantiomer's properties were thoroughly investigated for potential applications.
對非對映異構體的特性進行了深入研究，以評估其潛在應用。
the synthesis yielded a racemic mixture containing a non-enantiomer component.
合成產生了一種含有非對映異構體成分的外消旋混合物。
regulatory guidelines require strict control of non-enantiomer levels in pharmaceutical products.
法規指南要求對藥品中的非對映異構體含量進行嚴格控制。
the chiral shift revealed the presence of a non-enantiomer in the sample.
手性位移揭示了樣本中存在非對映異構體。
we developed a new method for selectively removing the non-enantiomer from the reaction mixture.
我們開發了一種新方法，用於選擇性地從反應混合物中去除非對映異構體。
the non-enantiomer's impact on the overall reaction kinetics was carefully assessed.
仔細評估了非對映異構體對整體反應動力學的影響。
the presence of a non-enantiomer can affect the drug's efficacy and safety profile.
非對映異構體的存在可能影響藥物的療效和安全性。
Explore frequently searched vocabulary
Want to learn vocabulary more efficiently? Download the DictoGo app and enjoy more vocabulary memorization and review features!
Download DictoGo Now